Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03636789
Other study ID # NIMAO/2017-01/GC-01
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 26, 2018
Est. completion date November 5, 2021

Study information

Verified date April 2022
Source Centre Hospitalier Universitaire de Nimes
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to investigate the prevalence of subclinical oculomotor disorders in a population of patients with radiologically isolated syndrome.


Recruitment information / eligibility

Status Completed
Enrollment 61
Est. completion date November 5, 2021
Est. primary completion date October 21, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - The patient must have given his informed consent and signed the consent form. - The patient must be affiliated or beneficiary of a health insurance plan. - The patient is at least 18 years old (=) and under 50 years old (=). - Patients with radiologically isolated syndrome according to the criteria of Okuda et al. (2009) - Diagnosis of a radiologically isolated syndrome confirmed by the national expert center of Nice for less than 3 years. Exclusion Criteria: - The subject participates in another study. - The subject is in an exclusion period determined by a previous study. - The subject is under guardianship, curatorship or safeguard of justice. - The patient is pregnant or breastfeeding - The subject refuses to sign the consent. - It is not possible to give the subject informed information. - Patient presenting a pathological neurological examination. - Patient with visual acuity less than 5/10 or with ocular instability

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Neurological consultation
study of horizontal, vertical, reflex and voluntary saccades, and of horizontal and vertical ocular pursuit by a BrainTracker eye-oculography system

Locations

Country Name City State
France Hôpital Neurologique Pierre Wertheimer Bron
France Hôpital Guy de Chauliac Montpellier
France Nice University Hospital Nice
France Nimes University Hospital Nîmes
France Pitié Salpêtrière University Hospital (APHP) Paris
France Toulouse University Hospital Toulouse

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nimes

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluation of the occurrence of oculomotor disorders using a video-oculographic recording system Day 0
Secondary To establish the prevalence of each of the different types of oculomotor abnormalities that constitute the oculomotor disorder number Day 0
Secondary To identify a correlation between oculomotor disorders and MRI abnormalities. Day 0
Secondary To identify a correlation between oculomotor disorders and the cognitive impairment test (Symbol Digit Modalities Test) Day 0
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT03269175 - BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies Phase 4